Your browser doesn't support javascript.
loading
Neurolysin knockout mice generation and initial phenotype characterization.
Cavalcanti, Diogo M L P; Castro, Leandro M; Rosa Neto, José C; Seelaender, Marilia; Neves, Rodrigo X; Oliveira, Vitor; Forti, Fábio L; Iwai, Leo K; Gozzo, Fabio C; Todiras, Mihail; Schadock, Ines; Barros, Carlos C; Bader, Michael; Ferro, Emer S.
Afiliação
  • Cavalcanti DM; From the Departments of Cell Biology and Development and.
  • Castro LM; Pharmacology, Support Center for Research in Proteolysis and Cell Signaling, Biomedical Sciences Institute, University of São Paulo, São Paulo, SP 05508-900, Brazil, the Department of Biophysics, Federal University of São Paulo, São Paulo, SP 04039-032, Brazil.
  • Rosa Neto JC; From the Departments of Cell Biology and Development and.
  • Seelaender M; From the Departments of Cell Biology and Development and.
  • Neves RX; From the Departments of Cell Biology and Development and.
  • Oliveira V; the Department of Biophysics, Federal University of São Paulo, São Paulo, SP 04039-032, Brazil.
  • Forti FL; the Department of Biochemistry, Support Center for Research in Proteolysis and Cell Signaling, Institute of Chemistry, University of São Paulo, São Paulo, SP 05508-000, Brazil.
  • Iwai LK; the Special Laboratory of Applied Toxinology, Center of Toxins, Immune Response and Cell Signaling, Butantan Institute, São Paulo, SP 05503-000, Brazil.
  • Gozzo FC; the Institute of Chemistry, State University of Campinas, Campinas, SP 13083-862, Brazil.
  • Todiras M; the Max-Delbrück-Center for Molecular Medicine, D-13125, Berlin, Germany, and.
  • Schadock I; the Max-Delbrück-Center for Molecular Medicine, D-13125, Berlin, Germany, and.
  • Barros CC; the Max-Delbrück-Center for Molecular Medicine, D-13125, Berlin, Germany, and the Department of Nutrition, Federal University of Pelotas, Pelotas, RS 96010-610, Brazil.
  • Bader M; the Max-Delbrück-Center for Molecular Medicine, D-13125, Berlin, Germany, and.
  • Ferro ES; Pharmacology, Support Center for Research in Proteolysis and Cell Signaling, Biomedical Sciences Institute, University of São Paulo, São Paulo, SP 05508-900, Brazil, eferro@usp.br.
J Biol Chem ; 289(22): 15426-40, 2014 May 30.
Article em En | MEDLINE | ID: mdl-24719317
The oligopeptidase neurolysin (EC 3.4.24.16; Nln) was first identified in rat brain synaptic membranes and shown to ubiquitously participate in the catabolism of bioactive peptides such as neurotensin and bradykinin. Recently, it was suggested that Nln reduction could improve insulin sensitivity. Here, we have shown that Nln KO mice have increased glucose tolerance, insulin sensitivity, and gluconeogenesis. KO mice have increased liver mRNA for several genes related to gluconeogenesis. Isotopic label semiquantitative peptidomic analysis suggests an increase in specific intracellular peptides in gastrocnemius and epididymal adipose tissue, which likely is involved with the increased glucose tolerance and insulin sensitivity in the KO mice. These results suggest the exciting new possibility that Nln is a key enzyme for energy metabolism and could be a novel therapeutic target to improve glucose uptake and insulin sensitivity.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Metaloendopeptidases / Intolerância à Glucose / Gluconeogênese Limite: Animals Idioma: En Revista: J Biol Chem Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Metaloendopeptidases / Intolerância à Glucose / Gluconeogênese Limite: Animals Idioma: En Revista: J Biol Chem Ano de publicação: 2014 Tipo de documento: Article